期刊文献+

原发性脾弥漫大B细胞淋巴瘤一例并文献复习 被引量:2

Primary splenic diffuse large B.cell lymphoma: one case report and literature review
原文传递
导出
摘要 目的探讨原发性脾弥漫大B细胞淋巴瘤(DLBCL)的临床病理学特征及治疗策略。方法回顾性分析1例原发性脾DLBCL患者的临床资料及病理切片,并复习相关文献。结果患者主要表现为左上腹疼痛,无发热及浅表淋巴结肿大,CT证实脾多发占位性病变伴脾门多发肿大淋巴结。行脾、胰尾切除术,病理确诊为DLBCL,免疫分型为生发中心B细胞型。外周血和骨髓检查结果正常。脾切除术后给予联合化疗,随访1年处于完全缓解期。结论原发性脾DLBCL罕见,患者早期无明显症状,手术探查是早期诊断的首选方法,病理学检查是诊断金标准。治疗首选脾切除术,术后辅助化疗及放疗可以提高患者生存率。
出处 《白血病.淋巴瘤》 CAS 2016年第4期234-236,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献6

二级参考文献60

  • 1吴宏菊,张清媛,陈德发,关小军,张伯龙,马军.美罗华联合CHOP方案与CHOP方案治疗初治弥漫性大B细胞淋巴瘤的临床对比研究[J].癌症,2005,24(12):1498-1502. 被引量:33
  • 2程月新,徐卫,李建勇,钱思轩,陆化,吴汉新,陈丽娟.非霍奇金淋巴瘤641例临床分析[J].南京医科大学学报(自然科学版),2006,26(9):837-840. 被引量:15
  • 3Vellenga E, van Putten WL, van' t Veer MB, et al. Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20 NHL: a prospective randomized HOVON trial[ J ]. Blood, 2008, 111 (2): 537-543.
  • 4E1 Gnaoui T, Dupuis J, Belhadj K, et al. Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high- dose therapy[J]. Ann Oncol, 2007,18(8): 1363-1368.
  • 5Arturo M. A decade of rituximab: improving survival outcomes in non-Hodgkin' s lymphoma [J]. Annu Rev Med, 2008, 59: 217-250.
  • 6Cheson BD, Homing S J, Coiffier B, et al. Report of an interna- tional workshop to standardize response criteria for non-Hodg- kin's lymphomas. NCI Sponsored International Working Group [J]. J Clin Oncol, 1999, 17(4): 1244.
  • 7Gregory SA, Trumoer L. Chemotherapy dose intensity in non- Hodgkin' s lymphoma: is dose intensity an emerging paradigm for better outcomes[J]. Ann Oncol, 2005, 16(9): 1413-1424.
  • 8Fisher RI, Miller TP, O' Connor OA. Diffuse aggressive lymphoma [J]. Hematology Am Soe Hematol Educ Program, 2004: 221-236.
  • 9Coiffier B, LePage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma [J]. N Engl J Med, 2002, 346 (4): 235-242.
  • 10Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large B-cell lymphoma: a randomized controlled trial by Mab Thera International Trail (MINT) Group [J]. Lancet Oncol, 2006, 7 (5): 379-391.

共引文献44

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部